Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume -, Issue -, Pages 115923
Publisher
Elsevier BV
Online
2023-11-01
DOI
10.1016/j.ejmech.2023.115923
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of PIKFYVE kinase interferes ESCRT pathway to suppress RNA virus replication
- (2023) Zhen Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Inhibition of Human Coronaviruses by Combinations of Host-Targeted and Direct-Acting Antivirals
- (2023) Patricia de León et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Identification of Four New Chemical Series of Small Drug‐Like Natural Products as Potential Neuropilin‐1 Inhibitors by Structure‐Based Virtual Screening: Pharmacophore‐Based Molecular Docking and Dynamics Simulation
- (2023) Abdellah Sabki et al. CHEMISTRY & BIODIVERSITY
- Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery–Genetics Alliance Perspective
- (2023) Cecilia Pozzi et al. Journal of Medicinal Chemistry
- Current thoughts on cellular functions of numb-associated kinases
- (2023) Chenxi Huang et al. MOLECULAR BIOLOGY REPORTS
- Inhibition of ACE2‐Spike Interaction by an ACE2 Binder Suppresses SARS‐CoV‐2 Entry
- (2022) Young‐Hee Shin et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Effect of an Inhibitor on the ACE2-Receptor-Binding Domain of SARS-CoV-2
- (2022) Gaurav Sharma et al. Journal of Chemical Information and Modeling
- Brilacidin, a COVID‐19 drug candidate, demonstrates broad‐spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell
- (2022) Yanmei Hu et al. JOURNAL OF MEDICAL VIROLOGY
- Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro
- (2022) Binli Mao et al. Emerging Microbes & Infections
- Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
- (2022) E Wesley Ely et al. Lancet Respiratory Medicine
- Identification of potent small molecule inhibitors of SARS-CoV-2 entry
- (2022) Sonia Mediouni et al. SLAS Discovery
- Dichlorophenylpyridine-Based Molecules Inhibit Furin through an Induced-Fit Mechanism
- (2022) Sven O. Dahms et al. ACS Chemical Biology
- ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion
- (2022) Georg Jocher et al. EMBO REPORTS
- Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19
- (2022) Jingyu Xiang et al. JOURNAL OF VIROLOGY
- A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
- (2022) Tirosh Shapira et al. NATURE
- Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike–ACE2 Interaction
- (2022) Scott E. Guimond et al. ACS Central Science
- Tuftsin: A Natural Molecule Against SARS-CoV-2 Infection
- (2022) Jiahao Huang et al. Frontiers in Molecular Biosciences
- Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells
- (2022) Simoun Icho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies
- (2022) Marwah Karim et al. ANTIVIRAL RESEARCH
- In vitro characterization of the furin inhibitor MI-1851: Albumin binding, interaction with cytochrome P450 enzymes and cytotoxicity
- (2022) Erzsébet Pászti-Gere et al. BIOMEDICINE & PHARMACOTHERAPY
- Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
- (2022) Jerneja Kladnik et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation
- (2022) Bryan J. Fraser et al. Nature Chemical Biology
- Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection
- (2022) Prabhakaran Kumar et al. VIROLOGY
- Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies
- (2022) Miao-Miao Zhao et al. Cell Discovery
- Two-pore channel blockade by phosphoinositide kinase inhibitors YM201636 and PI-103 determined by a histidine residue near pore-entrance
- (2022) Canwei Du et al. Communications Biology
- PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19
- (2022) James Logue et al. Communications Biology
- Expression profiles of respiratory V-ATPase and calprotectin in SARS-CoV-2 infection
- (2022) Yapeng Hou et al. Cell Death Discovery
- Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of SARS‐CoV‐2 Infection and COVID‐19
- (2022) Arun K. Ghosh et al. ChemMedChem
- Mechanism of N-0385 blocking SARS-CoV-2 to treat COVID-19 based on molecular docking and molecular dynamics
- (2022) Jun-Feng Cao et al. Frontiers in Microbiology
- Targeting SARS-CoV-2 and host cell receptor interactions
- (2022) Siew Pheng Lim ANTIVIRAL RESEARCH
- Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1
- (2022) Mei Hashizume et al. ANTIVIRAL RESEARCH
- Hypothesis: Efficacy of early treatments with some NSAIDs in COVID‐19: Might it also depend on their direct and/or indirect zinc chelating ability?
- (2022) Loris Zamai BRITISH JOURNAL OF PHARMACOLOGY
- Lysosomal ion channels involved in cellular entry and uncoating of enveloped viruses: Implications for therapeutic strategies against SARS-CoV-2
- (2021) Zhuangzhuang Zhao et al. CELL CALCIUM
- AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells
- (2021) Shuai Wang et al. CELL RESEARCH
- Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design
- (2021) Xuhua Xia Viruses-Basel
- SARS-CoV-2 protein drug targets landscape: a potential pharmacological insight view for the new drug development
- (2021) Chiranjib Chakraborty et al. Expert Review of Clinical Pharmacology
- Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture
- (2021) Allison Bakovic et al. Viruses-Basel
- Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
- (2021) Markus Hoffmann et al. EBioMedicine
- Upregulation of the Renin–Angiotensin System Pathways and SARS-CoV-2 Infection: The Rationale for the Administration of Zinc-Chelating Agents in COVID-19 Patients
- (2021) Loris Zamai Cells
- A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells
- (2021) Drake M. Mellott et al. ACS Chemical Biology
- Novel Compounds Targeting Neuropilin Receptor 1 with Potential To Interfere with SARS-CoV-2 Virus Entry
- (2021) Samantha Perez-Miller et al. ACS Chemical Neuroscience
- Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies
- (2021) Akalesh Kumar Verma et al. BIOMEDICINE & PHARMACOTHERAPY
- SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
- (2021) Krishnaprasad Baby et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Molecular basis of the new COVID-19 target neuropilin-1 in complex with SARS-CoV-2 S1 C-end rule peptide and small-molecule antagonists
- (2021) Methus Klaewkla et al. JOURNAL OF MOLECULAR LIQUIDS
- Mechanism of Ligand Recognition by Human ACE2 Receptor
- (2021) Apurba Bhattarai et al. Journal of Physical Chemistry Letters
- Milk Peptides as Novel Multi‐Targeted Therapeutic Candidates for SARS-CoV2
- (2021) H. Pradeep et al. PROTEIN JOURNAL
- Molecular basis of V-ATPase inhibition by bafilomycin A1
- (2021) Rong Wang et al. Nature Communications
- OFF-State-Specific Inhibition of the Proprotein Convertase Furin
- (2021) Sven O. Dahms et al. ACS Chemical Biology
- Heparanase as a Potential Player in SARS-CoV-2 Infection and Induced-Coagulopathy
- (2021) Safa Kinaneh et al. BIOSCIENCE REPORTS
- From Cancer to COVID‐19: A Perspective on Targeting Heparan Sulfate‐Protein Interactions
- (2021) Mohit Chhabra et al. CHEMICAL RECORD
- Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity
- (2021) Rania Hamdy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting the glycans: A paradigm for host‐targeted and COVID‐19 drug design
- (2021) Fatemeh Pourrajab JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Self-Masked Aldehyde Inhibitors: A Novel Strategy for Inhibiting Cysteine Proteases
- (2021) Linfeng Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Host proviral and antiviral factors for SARS-CoV-2
- (2021) Lu Lv et al. VIRUS GENES
- The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19
- (2021) Kun Li et al. mBio
- Characterization of the Modulatory Effect of Hydroxychloroquine on ACE2 Activity: New Insights in relation to COVID-19
- (2021) Juan E. Tichauer et al. Biomed Research International
- Cellular host factors for SARS-CoV-2 infection
- (2021) Jim Baggen et al. Nature Microbiology
- Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
- (2021) Amal Mahmoud et al. Heliyon
- Which ones, when and why should renin-angiotensin system inhibitors work against COVID-19?
- (2021) Mariele Montanari et al. Advances in Biological Regulation
- RdRp inhibitors and COVID-19: Is molnupiravir a good option?
- (2021) Seyed Mohammad Reza Hashemian et al. BIOMEDICINE & PHARMACOTHERAPY
- Potential of turmeric-derived compounds against RNA‐dependent RNA polymerase of SARS‐CoV‐2: An in-silico approach
- (2021) Rahul Singh et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
- (2021) Elisa Costanzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals
- (2021) Yusuf Şimşek et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Mechanisms of SARS-CoV-2 entry into cells
- (2021) Cody B. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
- (2021) Matthew Mahoney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of Microbial Metabolite Leupeptin in the Treatment of COVID-19 by Traditional Chinese Medicine Herbs
- (2021) Lifeng Fu et al. mBio
- Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity
- (2021) Maria Laura Saiz et al. Clinical Epigenetics
- A Review of Small Molecule Inhibitors and Functional Probes of Human Cathepsin L
- (2020) Dibyendu Dana et al. MOLECULES
- Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs
- (2020) Sangeun Jeon et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
- (2020) Zhongliang Wang et al. CLINICAL INFECTIOUS DISEASES
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- ACE2, the Receptor that Enables Infection by SARS‐CoV‐2: Biochemistry, Structure, Allostery and Evaluation of the Potential Development of ACE2 Modulators
- (2020) Lissy Z. F. Gross et al. ChemMedChem
- Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
- (2020) Yuan-Lin Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Two-Pore Channels: Current Progress and Future Challenges
- (2020) Xuhui Jin et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2
- (2020) Thomas Mandel Clausen et al. CELL
- Insights into Lysosomal PI(3,5)P2 Homeostasis from a Structural-Biochemical Analysis of the PIKfyve Lipid Kinase Complex
- (2020) Joshua A. Lees et al. MOLECULAR CELL
- NARINGENIN IS A POWERFUL INHIBITOR OF SARS-CoV-2 INFECTION IN VITRO
- (2020) Nicola Clementi et al. PHARMACOLOGICAL RESEARCH
- Neuropilin-1 is a host factor for SARS-CoV-2 infection
- (2020) James L. Daly et al. SCIENCE
- Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects
- (2020) Ya-Wen Cheng et al. Cell Reports
- Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients
- (2020) Baranca Buijsers et al. EBioMedicine
- Peptide and peptide-based inhibitors of SARS-CoV-2 entry
- (2020) Desiree Schütz et al. ADVANCED DRUG DELIVERY REVIEWS
- Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges
- (2020) Hongpeng Jia et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
- (2020) Sk. Abdul Amin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques
- (2020) Timothy N. Hoang et al. CELL
- Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19
- (2020) Xiyuan Bai et al. MEDICAL HYPOTHESES
- Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin
- (2020) Courtney J. Mycroft-West et al. THROMBOSIS AND HAEMOSTASIS
- The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules
- (2020) Kirill Gorshkov et al. ACS Infectious Diseases
- Dispirotripiperazine-core compounds, their biological activity with a focus on broad antiviral property, and perspectives in drug design (mini-review)
- (2020) Anna Egorova et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- TMPRSS2 contributes to virus spread and immunopathology in the airways of murine models after coronavirus infection
- (2019) Naoko Iwata-Yoshikawa et al. JOURNAL OF VIROLOGY
- A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis
- (2019) Gaurav Sharma et al. Autophagy
- Small molecule PIKfyve inhibitors as cancer therapeutics: Translational promises and limitations
- (2019) Ognian C. Ikonomov et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Discovery of novel nonpeptide small-molecule NRP1 antagonists: Virtual screening, molecular simulation and structural modification
- (2019) Kewen Peng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- ADAM proteases: Emerging role and targeting of the non-catalytic domains
- (2019) Nayanendu Saha et al. CANCER LETTERS
- NRPa-308, a new neuropilin-1 antagonist, exerts in vitro anti-angiogenic and anti-proliferative effects and in vivo anti-cancer effects in a mouse xenograft model
- (2018) Wang-Qing Liu et al. CANCER LETTERS
- Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells
- (2018) Jonathan Powell et al. JOURNAL OF MEDICINAL CHEMISTRY
- NAADP-dependent Ca2+ signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system
- (2018) Gihan S. Gunaratne et al. CELL CALCIUM
- Carbohydrate-based peptidomimetics targeting neuropilin-1: Synthesis, molecular docking study and in vitro biological activities
- (2016) Mylène Richard et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Inhibition of c-Rel DNA binding is critical for the anti-inflammatory effects of novel PIKfyve inhibitor
- (2016) Masaomi Terajima et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Vacuolin-1 inhibits autophagy by impairing lysosomal maturation via PIKfyve inhibition
- (2016) Osamu Sano et al. FEBS LETTERS
- Kinetic analysis and molecular modeling of the inhibition mechanism of roneparstat (SST0001) on human heparanase
- (2016) Daniele Pala et al. GLYCOBIOLOGY
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- (2016) Nan Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The structure of a furin-antibody complex explains non-competitive inhibition by steric exclusion of substrate conformers
- (2016) Sven O. Dahms et al. Scientific Reports
- Protease inhibitors targeting coronavirus and filovirus entry
- (2015) Yanchen Zhou et al. ANTIVIRAL RESEARCH
- Synthesis and Biological Evaluation of Indolyl-Pyridinyl-Propenones Having Either Methuosis or Microtubule Disruption Activity
- (2015) Christopher J. Trabbic et al. JOURNAL OF MEDICINAL CHEMISTRY
- Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease
- (2015) Lidia Anguiano et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment
- (2015) Yasuteru Sakurai et al. SCIENCE
- Discovery of novel inhibitors of vascular endothelial growth factor-A–Neuropilin-1 interaction by structure-based virtual screening
- (2014) Anna Starzec et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure–activity relationship study, target identification, and pharmacological characterization of a small molecular IL-12/23 inhibitor, APY0201
- (2014) Nobuhiko Hayakawa et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure-based discovery of a small non-peptidic Neuropilins antagonist exerting in vitro and in vivo anti-tumor activity on breast cancer model
- (2014) Lucia Borriello et al. CANCER LETTERS
- PIKfyve, a Class III PI Kinase, Is the Target of the Small Molecular IL-12/IL-23 Inhibitor Apilimod and a Player in Toll-like Receptor Signaling
- (2013) Xinming Cai et al. CHEMISTRY & BIOLOGY
- Targeting VEGF signalling via the neuropilin co-receptor
- (2012) Snezana Djordjevic et al. DRUG DISCOVERY TODAY
- Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate
- (2011) Anna Lundin et al. ANTIVIRAL RESEARCH
- Integration of Virtual and High Throughput Screening in Lead Discovery Settings
- (2011) Timea Polgar et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Virtual High Throughput Screening in New Lead Identification
- (2011) Preethi Badrinarayan et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
- (2011) Jianshe Lang et al. PLoS One
- Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1
- (2010) Alexandre Novoa et al. BIOORGANIC & MEDICINAL CHEMISTRY
- In silico fragment-based drug design
- (2010) Zenon D Konteatis Expert Opinion on Drug Discovery
- Small Molecule Inhibitors of the Neuropilin-1 Vascular Endothelial Growth Factor A (VEGF-A) Interaction
- (2010) Ashley Jarvis et al. JOURNAL OF MEDICINAL CHEMISTRY
- A selective PIKfyve inhibitor blocks PtdIns(3,5)P2 production and disrupts endomembrane transport and retroviral budding
- (2008) Harold B J Jefferies et al. EMBO REPORTS
- Assessment of Chemical Coverage of Kinome Space and Its Implications for Kinase Drug Discovery
- (2008) Paul Bamborough et al. JOURNAL OF MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started